- $26.27m
- $39.77m
- $65.27m
Cosmos Health Inc reports results for the quarter ended in June - Earnings Summary
Cosmos Health Inc expected to post a loss of 14 cents a share - Earnings Preview
Cosmos Health Inc expected to post a loss of 14 cents a share - Earnings Preview
Cosmos Health Inc reports results for the quarter ended in January - Earnings Summary
Brief: Cana Secures Contract Manufacturing Agreement With Australia's Humacology
Cosmos Health Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Cosmos Health Receives Nasdaq Notice On Late Filing Of Its Form 10-K
Cosmos Health Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Cosmos Health Received Regulatory Approval To Sell Its Sky Premium Life Vitamins & Food Supplements In United Arab Emirates Market
Brief: Cosmos Health Enters Into Definitive Agreement To Acquire Type-2 Diabetes Treatment Diabit-Is X
Brief: Cosmos Health Enters Into Agreement To Acquire Rights For Wipo-Filed Patent On Drug Targeting Cns Cancers
Brief: Cosmos Health Actively Exploring Spinoff Of R&D Division Into A Publicly Listed Standalone Biotech Company
Virax Biolabs rises on COVID, influenza rapid test launch deal
Brief: Virax Biolabs Group Announces Purchase Order To Launch Covid-19 And Influenza A+B Antigen Combo Rapid Tests With Cosmos Health
U.S. STOCKS ON THE MOVE-Tesla, Madrigal, Walt Disney
U.S. STOCKS ON THE MOVE-Tesla, Madrigal, Qumu, Zymeworks
U.S. STOCKS ON THE MOVE-Tesla, Neptune Wellness, Ardelyx
Cosmos Holdings announces reverse stock split; shares tank
U.S. STOCKS ON THE MOVE-Energy firms, Tesla, Activision Blizzard